UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012943 |
|---|---|
| Receipt number | R000015136 |
| Scientific Title | Phase I Dose-escalation, Safety / Tolerability and Preliminary Efficacy Study of Intratumoral Administration of GEN0101 in Patients with Advanced Melanoma. |
| Date of disclosure of the study information | 2014/03/01 |
| Last modified on | 2017/01/17 14:35:28 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/01/24 16:45:35 | ||
| 2 | Update | 2014/07/28 10:05:15 | Key exclusion criteria Key exclusion criteria |
|
| 3 | Update | 2015/01/06 13:48:17 | Recruitment status Anticipated trial start date |
|
| 4 | Update | 2015/09/11 13:02:08 | Basic objectives2 |
|
| 5 | Update | 2015/09/11 13:27:40 | Key inclusion criteria Key exclusion criteria |
|
| 6 | Update | 2015/09/11 13:31:31 | Organization Organization |
|
| 7 | Update | 2015/09/11 13:53:54 | Category of Funding Organization |
|
| 8 | Update | 2016/08/02 09:53:58 | Key exclusion criteria |
|
| 9 | Update | 2016/08/02 09:57:07 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 10 | Update | 2017/01/17 14:35:28 | Recruitment status |
